| Bafna Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532989 |
NSE Symbol : BAFNAPH |
P/E(TTM) : 35.45 |
|
ISIN Demat : INE878I01022 |
Div & Yield% : 0.00 |
EPS(TTM) : 4.69 |
|
Book Value(₹) : 40.64 |
Market Cap(₹Cr) : 393.29 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 42.24 | 38.29 | 35.47 | 34.62 | 39.06 | 33.19 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 42.24 | 38.29 | 35.47 | 34.62 | 39.06 | 33.19 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.76 | 1.22 | 1.18 | 0.60 | 1.03 | 0.19 |
| Total Income | 44.00 | 39.51 | 36.65 | 35.22 | 40.09 | 33.38 |
| Total Expenditure | 38.69 | 35.24 | 31.19 | 29.56 | 37.74 | 30.14 |
| PBIDT | 5.31 | 4.27 | 5.46 | 5.66 | 2.35 | 3.24 |
| Interest | 1.03 | 0.86 | 0.86 | 0.91 | 0.82 | 0.64 |
| PBDT | 4.28 | 3.41 | 4.60 | 4.76 | 1.53 | 2.60 |
| Depreciation | 1.66 | 1.57 | 1.47 | 1.37 | 0.22 | 1.66 |
| Tax | -0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 2.75 | 1.84 | 3.12 | 3.39 | 1.31 | 0.95 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | -1.79 | -0.01 |
| Adjusted Profit After Extra-ordinary item | 2.75 | 1.84 | 3.12 | 3.39 | 3.10 | 0.96 |
| EPS (Unit Curr.) | 1.16 | 0.78 | 1.32 | 1.43 | 0.55 | 0.40 |
| EPS (Adj) (Unit Curr.) | 1.16 | 0.78 | 1.32 | 1.43 | 0.55 | 0.40 |
| Calculated EPS (Unit Curr.) | 1.16 | 0.78 | 1.32 | 1.43 | 0.55 | 0.40 |
| Calculated EPS (Adj) (Unit Curr.) | 1.16 | 0.78 | 1.32 | 1.43 | 0.55 | 0.40 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.65 | 3.11 | 5.28 | 5.73 | 2.22 | 1.60 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.65 | 3.11 | 5.28 | 5.73 | 2.22 | 1.60 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 23.66 | 23.66 | 23.66 | 23.66 | 23.66 | 23.66 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 12.57 | 11.15 | 15.39 | 16.35 | 6.02 | 9.76 |
| PBDTM(%) | 10.13 | 8.91 | 12.97 | 13.75 | 3.92 | 7.83 |
| PATM(%) | 6.51 | 4.81 | 8.80 | 9.79 | 3.35 | 2.86 |
